Omeros (OMER) Corporation announced that the U.S. Centers for Medicare & Medicaid Services has assigned a permanent Healthcare Common Procedure Coding System J-code for YARTEMLEA. The J-code for YARTEMLEA simplifies and streamlines billing and reimbursement for patients covered by U.S. government program and commercial payers. The J-code will become effective July 1, 2026.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMER:
- Omeros Turns Corner With Novo Deal, YARTEMLEA Launch
- Closing Bell Movers: Nike slides 9% after Q3 results, soft outlook
- Omeros reports Q4 EPS $1.22, consensus 36c
- Omeros Corporation (OMER) Q4 Earnings Cheat Sheet
- Omeros: YARTEMLEA Cash Flows Funding High-Upside OncotoX-AML Pipeline, Supporting Buy Rating and $40 Target